HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deng-Chyang Wu Selected Research

Dexlansoprazole

1/2019Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial.
1/2019A comparison between dexlansoprazole modified release-based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial.
12/2017First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease.
3/2016A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Deng-Chyang Wu Research Topics

Disease

56Infections
10/2022 - 06/2002
47Neoplasms (Cancer)
06/2022 - 11/2003
30Stomach Neoplasms (Stomach Cancer)
06/2022 - 03/2004
16Carcinogenesis
06/2022 - 01/2005
11Peptic Ulcer (Peptic Ulcers)
01/2020 - 07/2003
9Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 04/2007
9Hemorrhage
01/2020 - 12/2004
8Neoplasm Metastasis (Metastasis)
08/2021 - 06/2006
8Adenocarcinoma
04/2021 - 07/2003
8Carcinoma (Carcinomatosis)
11/2018 - 11/2003
8Esophageal Squamous Cell Carcinoma
12/2016 - 09/2005
7Esophageal Neoplasms (Esophageal Cancer)
02/2013 - 01/2003
6Inflammation (Inflammations)
06/2022 - 07/2007
5Gastritis
11/2019 - 06/2017
5Gastroesophageal Reflux (GERD)
01/2019 - 01/2013
5Esophagitis
01/2019 - 01/2013
5Breast Neoplasms (Breast Cancer)
05/2016 - 01/2003
4Hepatocellular Carcinoma (Hepatoma)
11/2018 - 02/2013
4Ulcer
01/2017 - 07/2003
4Albuminuria
05/2013 - 12/2008
3Dyspepsia (Indigestion)
01/2021 - 09/2002
3Dysbiosis
12/2020 - 08/2018
3Colonic Neoplasms (Colon Cancer)
01/2020 - 08/2015
3Adenoma (Adenomas)
01/2019 - 09/2013
3Lymphatic Metastasis
11/2018 - 06/2005
3Tuberculosis (Tuberculoses)
10/2018 - 06/2012
2Rectal Neoplasms (Rectal Cancer)
01/2020 - 12/2007
2Mouth Neoplasms (Oral Cancer)
01/2020 - 10/2008
2Chronic Renal Insufficiency
01/2020 - 09/2016
2Chronic Kidney Failure (Chronic Renal Failure)
01/2020 - 08/2017
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2019 - 10/2018
2Stomach Diseases
04/2018 - 01/2018
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2018 - 06/2015

Drug/Important Bio-Agent (IBA)

16Biomarkers (Surrogate Marker)IBA
06/2022 - 02/2010
14Proton Pump InhibitorsIBA
10/2022 - 03/2006
13Proteins (Proteins, Gene)FDA Link
06/2022 - 07/2003
8Amoxicillin (Wymox)FDA LinkGeneric
10/2021 - 06/2002
8BismuthIBA
08/2018 - 03/2006
7Urea (Carbamide)FDA LinkGeneric
04/2021 - 07/2003
7Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 03/2006
6Hemoglobins (Hemoglobin)IBA
06/2022 - 01/2013
6Peptides (Polypeptides)IBA
04/2020 - 01/2013
6Clarithromycin (Biaxin)FDA LinkGeneric
01/2019 - 06/2002
6Messenger RNA (mRNA)IBA
10/2008 - 06/2005
5Levofloxacin (Levaquin)FDA Link
10/2021 - 05/2009
5Biological ProductsIBA
12/2020 - 07/2006
5Pharmaceutical PreparationsIBA
01/2018 - 12/2015
5Rabeprazole (Aciphex)FDA Link
01/2017 - 08/2010
4Tetracycline (Achromycin)FDA LinkGeneric
10/2021 - 02/2014
4Tumor Biomarkers (Tumor Markers)IBA
12/2020 - 02/2013
4DexlansoprazoleFDA Link
01/2019 - 03/2016
4Esomeprazole (Nexium)FDA Link
01/2019 - 05/2015
4UreaseIBA
01/2018 - 03/2005
4AcidsIBA
12/2017 - 01/2013
4Neutralizing AntibodiesIBA
05/2016 - 01/2014
4AlbuminsIBA
05/2013 - 02/2008
4Codon (Codons)IBA
02/2010 - 01/2003
4arginylarginine (Arg-Arg)IBA
09/2009 - 01/2003
4AntigensIBA
01/2008 - 07/2003
4Carcinoembryonic AntigenIBA
04/2007 - 06/2005
3Glucose (Dextrose)FDA LinkGeneric
06/2022 - 09/2013
3Histidine (L-Histidine)FDA Link
06/2022 - 01/2003
3Interleukin-10 (Interleukin 10)IBA
08/2021 - 01/2011
3Virulence Factors (Pathogenicity Factors)IBA
04/2021 - 01/2013
3vedolizumabIBA
01/2021 - 10/2018
3GlobinsIBA
04/2020 - 01/2013
3hepatoma-derived growth factorIBA
01/2019 - 06/2015
3Metronidazole (Metric)FDA LinkGeneric
01/2019 - 05/2011
3Untranslated RNA (Noncoding RNA)IBA
10/2017 - 08/2015
3CytokinesIBA
06/2017 - 01/2011
3Cytochrome P-450 CYP2C19IBA
05/2016 - 08/2010
3ErbB Receptors (EGF Receptor)IBA
03/2016 - 02/2010
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
02/2016 - 06/2005
3OsteopontinIBA
11/2011 - 09/2008
3Transcription Factors (Transcription Factor)IBA
09/2009 - 09/2007
3Telomerase (Telomerase Reverse Transcriptase)IBA
07/2006 - 09/2005
2Endoplasmic Reticulum Chaperone BiPIBA
06/2022 - 01/2014
2hemoglobin ASIBA
06/2022 - 04/2020
2Aspartic Acid (Aspartate)FDA Link
06/2022 - 01/2020
2FluoroquinolonesIBA
10/2021 - 09/2017
2Interleukin-17 (Interleukin 17)IBA
08/2021 - 10/2012
2DNA (Deoxyribonucleic Acid)IBA
04/2021 - 04/2018
2Therapeutic UsesIBA
12/2020 - 05/2015
2TrypsinIBA
04/2020 - 05/2013
2Estradiol (Delestrogen)FDA LinkGeneric
11/2019 - 05/2016
2GoldIBA
04/2019 - 10/2018
2Lansoprazole (Prevacid)FDA LinkGeneric
01/2019 - 07/2013
2Antiviral Agents (Antivirals)IBA
11/2018 - 12/2012
2Celecoxib (Celebrex)FDA Link
01/2018 - 10/2009
2Pantoprazole (Protonix)FDA LinkGeneric
01/2018 - 12/2004
2LigandsIBA
01/2018 - 08/2015

Therapy/Procedure

49Therapeutics
10/2022 - 06/2004
10Drug Therapy (Chemotherapy)
06/2022 - 03/2008
4Lasers (Laser)
01/2017 - 12/2008
3Length of Stay
01/2021 - 01/2005
3Esophagectomy
02/2013 - 01/2005
2Radiotherapy
08/2021 - 03/2008
2Nutritional Support (Artificial Feeding)
01/2021 - 01/2008
2Fecal Microbiota Transplantation
01/2020 - 09/2019
2Ligation
01/2018 - 01/2017